Interferon beta 1b Subcutaneous Injection Treatment Report
See More Treatments
See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Betaferon, Betaseron
What is Interferon beta 1b Subcutaneous Injection?
Interferon beta-1b is a drug in the interferon family used to treat multiple sclerosis. It is administered by sub-cutaneous injection and has been shown to slow the advance of the affliction as well as reduce the frequency of attacks.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
Reasons Taken
443 patients in the community are taking or have taken Interferon beta 1b Subcutaneous Injection.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my MS progress | 373 | 89% |
| Other | 17 | 4% |
| Fatigue | 6 | 1% |
| Stiffness/spasticity | 4 | <1% |
| Don't know | 3 | <1% |
| General health | 2 | <1% |
| disease-related symptoms | 2 | <1% |
| Bladder problems | 2 | <1% |
| Sexual dysfunction | 1 | <1% |
| Excessive daytime sleepiness (somnolence) | 1 | <1% |
| Pain | 1 | <1% |
| Brain fog | 1 | <1% |
| Headaches/ Migraines | 1 | <1% |
| Vision | 1 | <1% |
| Difficulty walking | 1 | <1% |
Dosages
Based on the patients currently taking Interferon beta 1b Subcutaneous Injection.
Top 10 (Show all)
All (Show Top 10)
| 0 mcg day | 0 mg day | 0 day | 0 mg none | 0 mg week | 0.125 mg week | 0.25 mg week | 0.3 mg week | 0.15 mg day | 0.125 mg day | 0.25 mcg day | 0.25 mg day | 0.25 day | 0.9 mg week | 1 mg week | 0 mg none | 0.15 mg day | 0.3 mcg day | 0.3 mg day | 0.44 mg day | 0.5 mg day | 0.5 day | 0.3 mg day | 0.75 mcg day | 0.75 mg day | 3 mg week | 1 g day | 1 mcg day | 1 mg day | 1 day | 4 mg week | 1.3 mg day | 1.5 mg day | 6.29987400251995 mg week | 1 mg day | 2 mg day | 3 mg day | 15 mg week | 2.5 mcg day | 20 mg day | 21 mcg day | 12.5 mg day | 25 mg day | 30 mg day | 44 mcg week | 40 mcg day | 40 mg day | 44 mcg day | 44 mg day | 300 mg week | 100 mcg day | 100 mg day | 200 mcg day | 200 mg day | 200 day | 125 mcg day | 250 mcg day | 250 mg day | 300 mg day | 250 mcg day | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
13
|
58
|
28
|
5
|
11
|
1
|
1
|
2
|
3
|
1
|
1
|
16
|
1
|
1
|
2
|
1
|
6
|
2
|
55
|
1
|
2
|
1
|
7
|
1
|
5
|
3
|
1
|
2
|
32
|
3
|
1
|
1
|
2
|
1
|
1
|
1
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
2
|
1
|
1
|
3
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
1
|
||
Duration
How long current patients have been taking Interferon beta 1b Subcutaneous Injection or how long patients were taking Interferon beta 1b Subcutaneous Injection before stopping.
Currently taking Interferon beta 1b Subcutaneous Injection
Stopped taking Interferon beta 1b Subcutaneous Injection
| Reason | # Patients | Percentage of patients | |
|---|---|---|---|
| Side effects too severe | 40 | 36% |  |
| Did not seem to work | 35 | 32% | |
| Doctor's advice | 31 | 28% | |
| Other | 30 | 27% | |
| Not indicated | 4 | 4% | |
| Course of treatment ended | 2 | 2% | |
| Personal research | 1 | 1% | |
Patient Reported Evaluations
Results from 11 patient evaluations. See the overall results and all individual evaluations.
Efficacy (Effect based on reason taken)
| Slight | 40% | 4 |
|---|---|---|
| None | 40% | 4 |
| Can't tell | 20% | 2 |
Slow my MS progress
Side-effects (as an overall problem)
| Severe | 27% | 3 |
|---|---|---|
| Moderate | 18% | 2 |
| Mild | 45% | 5 |
| None | 9% | 1 |
Top reported side-effects include: Depression, flu like symtoms, Bruising
Summary results are based on 11 individual responses. For more information, see overall results for Adherence, Burden and Cost.
Individual Patient Reported Evaluations (2 of 11)
-
- feathers4me
- Sensation: severe
- Overall: moderate
- Cognition: moderate
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: moderate
- Walking: severe
- See profile
-
by feathers4me
Feb 04, 2008
- EfficacySlight
- Side-effectsModerate
- Slow my MS progress
- See full evaluation
-
0 helpful marks
-
- OBXGemini
- Sensation: moderate
- Overall: mild
- Cognition: mild
- Vision: moderate
- Speech: mild
- Swallowing: mild
- Upper limb: moderate
- Walking: moderate
- See profile
-
by OBXGemini
Aug 19, 2008
- EfficacyNone
- Side-effectsMild
- Slow my MS progress
- See full evaluation
-
0 helpful marks
See all evaluation results for Interferon beta 1b Subcutaneous Injection